Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182050.RAfDL6_5SYHZW-fmkfA9EoB84O6TlYbZ-dkXs_QvU3rZE130_provenance.
• NP221753.RAiFOsOfFZLXc4HZ1azfPB4okxlO0lBgOsi45rEjo9khE130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221753.RAiFOsOfFZLXc4HZ1azfPB4okxlO0lBgOsi45rEjo9khE130_provenance.
• NP243078.RAgkCSYxzUqxpjnvkEl6y5cgqnh0XFs_rw4my7GIUY7M8130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP243078.RAgkCSYxzUqxpjnvkEl6y5cgqnh0XFs_rw4my7GIUY7M8130_provenance.
• NP755564.RAt00sNTfKdr2AhZ7507lDu-4feEQSMlZOEX9sShY-QOY130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755564.RAt00sNTfKdr2AhZ7507lDu-4feEQSMlZOEX9sShY-QOY130_provenance.
• assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP408345.RAIfUhdmeijq_o40OInWZ84E9bzXcpjz4zrfu-Ey-I67s130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408345.RAIfUhdmeijq_o40OInWZ84E9bzXcpjz4zrfu-Ey-I67s130_provenance.
• NP508239.RA9SVcnIf8BYJsXaS67Hyf0kunKRjBFvhpoUHzvKO76XY130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP508239.RA9SVcnIf8BYJsXaS67Hyf0kunKRjBFvhpoUHzvKO76XY130_provenance.
• NP548694.RA-GmBspQxUShFSQ4Pr8jIagMSffwvbzHpXaC3j0H7xek130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548694.RA-GmBspQxUShFSQ4Pr8jIagMSffwvbzHpXaC3j0H7xek130_provenance.
• assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_provenance.
• assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP403896.RAb4vZd444Dg5IMApDCGe5sdo-hkH0apQLaeHmBy-0t1I130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP403896.RAb4vZd444Dg5IMApDCGe5sdo-hkH0apQLaeHmBy-0t1I130_provenance.
• NP718189.RA3tikbVkq2dajwO1PNFXV2NYW0XI2EjLIlNkGYinUyFc130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718189.RA3tikbVkq2dajwO1PNFXV2NYW0XI2EjLIlNkGYinUyFc130_provenance.
• NP863672.RA8Cs8Y1iBR9PEy53P9pLEKOt8dVuHtlzsEzxIAzPOZoY130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863672.RA8Cs8Y1iBR9PEy53P9pLEKOt8dVuHtlzsEzxIAzPOZoY130_provenance.
• NP913794.RA6elgTPyrAEa2eaSYRkMQZXPojRC57x2Dw9jEWkSslYo130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913794.RA6elgTPyrAEa2eaSYRkMQZXPojRC57x2Dw9jEWkSslYo130_provenance.
• NP326720.RAUR5MEIfTYrsH9szXYS_qApc6ObOxeSyIJdPKqCarsPA130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326720.RAUR5MEIfTYrsH9szXYS_qApc6ObOxeSyIJdPKqCarsPA130_provenance.
• NP329134.RAXGwZ38unkh1IgYTjqEixpuO6_PBenLX9NJrD7LrRL1Y130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329134.RAXGwZ38unkh1IgYTjqEixpuO6_PBenLX9NJrD7LrRL1Y130_provenance.
• NP822705.RAWdLeXShU5XMN-AHEMiHFWzhAQ8ofWfGNyTm4MCR9l_I130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822705.RAWdLeXShU5XMN-AHEMiHFWzhAQ8ofWfGNyTm4MCR9l_I130_provenance.
• NP881623.RARSRozzRIc5luxYRY8nF5xWPOGDw_TogrUhwjeH0w3Ck130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881623.RARSRozzRIc5luxYRY8nF5xWPOGDw_TogrUhwjeH0w3Ck130_provenance.
• NP511781.RAK93gVv5gj-Juo5sz6zJNft4EJXdhwE27DgruOODvHDw130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP511781.RAK93gVv5gj-Juo5sz6zJNft4EJXdhwE27DgruOODvHDw130_provenance.
• assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP869684.RAe4b7n_uB8qOqXB5uIriSjZtI0JeP2_ZbNNtgFakfjO4130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869684.RAe4b7n_uB8qOqXB5uIriSjZtI0JeP2_ZbNNtgFakfjO4130_provenance.
• NP869686.RASFrxIjQj2OfMHGxLQ-1AqsbNGQb2h04rTh7DQUvWYwI130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869686.RASFrxIjQj2OfMHGxLQ-1AqsbNGQb2h04rTh7DQUvWYwI130_provenance.
• NP737740.RAN1R8ifTJGK72FBCDPxpsScV7zTGke0uJqJVoY7VVyGo130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP737740.RAN1R8ifTJGK72FBCDPxpsScV7zTGke0uJqJVoY7VVyGo130_provenance.
• NP879859.RAiWSAsn7gA9slc-JkjFLTfpRg1WMnFWFQBf3gSIhw09c130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879859.RAiWSAsn7gA9slc-JkjFLTfpRg1WMnFWFQBf3gSIhw09c130_provenance.
• NP869690.RArkYM3LAVK7Uol58BUoyCwMdXFQhTiA3JGaNP91GV-3E130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869690.RArkYM3LAVK7Uol58BUoyCwMdXFQhTiA3JGaNP91GV-3E130_provenance.
• NP644276.RAMFtLiQPOsiUg-dizkE4iY0SqJH1fB_XIMXKo-nfiA3U130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644276.RAMFtLiQPOsiUg-dizkE4iY0SqJH1fB_XIMXKo-nfiA3U130_provenance.
• NP786865.RAJ1Q_-4B7szAGuut2BZ3clanzMC8j94cCCN_rLrqnbYc130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786865.RAJ1Q_-4B7szAGuut2BZ3clanzMC8j94cCCN_rLrqnbYc130_provenance.
• NP869688.RAPyVQQnm7G2zBWe-fvxNZ97LjsZJY-mBYAIJ_FlbtMx4130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869688.RAPyVQQnm7G2zBWe-fvxNZ97LjsZJY-mBYAIJ_FlbtMx4130_provenance.
• NP869689.RAFkkq1z3DIGfWPmn1UE-P_Ayvef2HTWkaKkuat01_dwQ130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869689.RAFkkq1z3DIGfWPmn1UE-P_Ayvef2HTWkaKkuat01_dwQ130_provenance.
• NP848301.RA4XeuIondPjFRGWq12ZKYVL_Ta8sj1oEqJ8AlWhagfp0130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848301.RA4XeuIondPjFRGWq12ZKYVL_Ta8sj1oEqJ8AlWhagfp0130_provenance.
• NP869685.RA9ZxoPb8kbsNeFrs6afIM6RIOk3n1N4YehQozH24LO4Y130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869685.RA9ZxoPb8kbsNeFrs6afIM6RIOk3n1N4YehQozH24LO4Y130_provenance.
• NP869687.RA93zLRz3_im7PKOG98F2oUBbAeVRr7DqOzvyzyuFmWtA130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869687.RA93zLRz3_im7PKOG98F2oUBbAeVRr7DqOzvyzyuFmWtA130_provenance.
• NP869691.RA7ENF8EwO3x70sdRtmcUDrCJFoV13tPWTypHgt78nnSY130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869691.RA7ENF8EwO3x70sdRtmcUDrCJFoV13tPWTypHgt78nnSY130_provenance.
• NP869692.RA2UzFiZVqftECLGhbcTLf50ciuXdAp_H_YXCrjXv8HGM130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869692.RA2UzFiZVqftECLGhbcTLf50ciuXdAp_H_YXCrjXv8HGM130_provenance.